February 25, 2009
There are a number of interesting cancer drugs in development that may receive approval this year. Many of them are from biotech rather than pharma and focused on niche indications. First up is Genzyme's Clolar (clofarabine), which was filed as a supplemental application in the US on November 24th...
Pharma Strategy Blog
[ Feed -
Focus -
Exclude ]
by
Sally Church
at 1:06 PM
February 18, 2009
Yes. I noticed the slightest hint of sarcasm in the title of this post. This post covers four commonly used measurement techniques that 9 times out of 10 work against the evolution of Reporting Squirrels into Analysis Ninjas. I’ll also admit that most of the times when I encounter them I might...
Occam's Razor by Avinash Kaushik
[ Feed -
Focus -
Exclude ]
by
Avinash Kaushik
at 4:51 AM
February 02, 2009
August Jackson has some interesting thoughts about social networking. It begins with the observation that social networking is now more popular than porn (he points out that this may need to be verified) and explores what that means relative to CI: It’s not a fad or flash in the pan. ...
Competitive Intelligence Marketplace
[ Feed -
Focus -
Exclude ]
by
Jon Lowder
at 8:00 AM
January 23, 2009
Ken Sawka has a nice post at the Outward Insights blog about companies' own versions of urban legends: Managers can hold similar myths, stereotypes, and distortions about competitors, industry conditions, or other business matters. It’s hard for executives, especially those who have been in th...
Competitive Intelligence Marketplace
[ Feed -
Focus -
Exclude ]
by
Jon Lowder
at 6:22 AM
December 10, 2008
From The Deal: How and why did the Big Three miss such an important strategic innovation in the industry? No doubt there were multiple factors, with insularity, mismanagement and union labor restrictions probably among them. But as Congress readies an auto bailout package and the industry contemplat...
Competitive Intelligence Marketplace
[ Feed -
Focus -
Exclude ]
by
Jon Lowder
at 5:29 PM
December 05, 2008
August Jackson left a great comment on the earlier post on Airbus's internal presentation on Boeings challenges with the 787 and I think it's worth posting his comment separately here: This is an interesting development, and it will indeed be very interesting to see how this plays out. As an...
Competitive Intelligence Marketplace
[ Feed -
Focus -
Exclude ]
by
Jon Lowder
at 6:50 AM
November 14, 2008
Arik Johnson is attending the CICI Shanghai event and has an excellent write up of the first day's events. Of particular interest are SCIP President Joe Goldberg's (Senior Director of Corporate Intelligence at Motorola) comments. Here's an excerpt I found particularly compelling: ...
Competitive Intelligence Marketplace
[ Feed -
Focus -
Exclude ]
by
Jon Lowder
at 9:13 AM
Arik Johnson is attending the CICI Shanghai event and has an excellent write up of the first day's events. Of particular interest are SCIP President Joe Goldberg's (Senior Director of Corporate Intelligence at Motorola) comments. Here's an excerpt I found particularly compelling: ...
Competitive Intelligence Marketplace
[ Feed -
Focus -
Exclude ]
by
Jon Lowder
at 9:13 AM
November 11, 2008
In today’s National Post a vague article entitled, Spying doesn’t pay, prattles on about ethics and warns about the weak moral fibre and criminality of competitive intelligence practitioners. I find it hard to get over pendants who don’t meet a payroll, deal with shareholders, or s...
The Confidential Resource
[ Feed -
Focus -
Exclude ]
by
Richard McEachin
at 4:48 PM
October 22, 2008
"Successful companies do not abandon their marketing strategies in a recession; they adapt them." John Quelch, Harvard Business School Yesterday, I was scanning my Google Reader for information on 'Marketing and Recession' and came across an HBR Working Knowledge article by Prof. John Quelch entitle...
Pharma Strategy Blog
[ Feed -
Focus -
Exclude ]
by
Sally Church
at 7:33 PM




